Press Releases

Jan 14, 2020

DeGette, others call on feds to take steps to combat 'growing threat'

WASHINGTON, D.C. – A bipartisan group of lawmakers – led by U.S. Rep. Diana DeGette (D-CO) – are raising concerns today about the increasing use of stimulants, such as cocaine and methamphetamine, among Americans in recent years.

Jan 13, 2020

Federal lawmakers want to know ‘what’s working and what’s not’ as they search for ways to stem nationwide crisis

Jan 9, 2020
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Francis Rooney (R-FL) are calling on their colleagues in the House to oppose the Trump administration’s latest attempt to gut one of the nation’s most effective environmental protection laws.
Jan 8, 2020
WASHINGTON, D.C. – A group of federal lawmakers today unveiled the framework of an ambitious new plan to help combat the global climate crisis by cutting the nation’s greenhouse gas emissions to net-zero by 2050.
Jan 3, 2020
WASHINGTON, D.C. – Following is a statement from U.S. Rep. Diana DeGette (D-CO) on the Trump Administration’s airstrike that killed Iranian military leader Qassem Soleimani:
Dec 18, 2019

WASHINGTON, D.C. – Speaker of the House Nancy Pelosi (D-CA) has asked U.S. Rep. Diana DeGette (D-CO) to serve as speaker pro tempore and preside over the U.S. House of Representatives for today’s debate on impeaching the president of the United States.

Dec 18, 2019

WASHINGTON, D.C. – Following is a statement from U.S. Rep. Diana DeGette (D-CO), who served as speaker pro tempore and presided over today’s impeachment debate, on the U.S. House of Representatives voting to impeach President Donald Trump:

Dec 12, 2019

WASHINGTON, D.C. – The U.S. House of Representatives today, by a vote of 230 – 192, approved a sweeping drug-pricing reform bill designed to help bring down the cost of prescription drugs for millions of Americans.

Dec 10, 2019

WASHINGTON, D.C. – Following is a statement from U.S. Rep. Diana DeGette (D-CO) on the articles of impeachment released today:

Dec 9, 2019

Hearing comes as concerns mount over FDA’s ability to effectively monitor foreign drug makers

WASHINGTON, D.C. – Forty percent of all prescription drugs approved for sale in the U.S. are manufactured overseas – but are they safe?

Pages